Global Gonorrhea Testing Market – Industry Trends and Forecast to 2030

Gonorrhea Testing Market Analysis and Size

As per the Centers for Disease Control and Prevention (CDC), the most frequent infectious disease among the youth is gonorrhea, which causes 820,000 new cases in the U.S. each year. Around 70% of the population among these 820,000 new cases is expected to be between 15 and 24 years old. As per the records of CDC, women aged over 25 years are more likely to develop gonorrhea. Additionally, having several sex partners, unprotected intercourse, or having oral or anal sex with a person suffering from sexually transmitted infection are all risk factors associated with gonorrhea.

Data Bridge Market Research analyses that the gonorrhea testing market, which was USD 8.13 billion in 2022, would rise to USD 15.63 billion by 2030 and is expected to undergo a CAGR of 8.5% during the forecast period from 2023 to 2030. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Gonorrhea Testing Market Scope and Segmentation

Market Definition

Gonorrhea is one of the most widespread sexually transmitted diseases, which is a bacterial infection spread via oral, anal, or vaginal sex with an infected person. Men can get painful urination, testicular enlargement, and pus discharge from gonorrhea. Women and men get these diseases at diverse rates. The initiation of symptoms ranges between 2 and 14 days for males and 7 and 21 days for women.

Global Gonorrhea Testing Market Dynamics

Drivers

• Growing Cases of STD

The high growth in the STD rate demands rapid use of gonorrhea testing. As per the data published by the WHO in 2022, more than 1 million sexually transmitted infections are acquired globally every day; most of them will be asymptomatic. It also specified that about 374 million new infections are yearly, with 1 out of 4 sexually transmitted infections such as trichomoniasis, chlamydia, gonorrhea, and syphilis. These diseases demand immediate testing to detect the responsible virus for faster treatment. Thus, this factor boosts market growth.

• Increasing Feasibility of Different Testing Methods

Different testing methods are developed for the advantage of the patients. Laboratory testing, including commercial/private and public health labs, is a tedious but more precise method. Although point-of-care testing, including testing kits, is more rapid, the results may not be precise. There is an observed major shift from traditional laboratory tests to quick and easy point-of-care tests because of the advantages offered by the point of care testing devices. Thus, this factor leads to market growth.

Opportunities

• Increasing Government Awareness with Gonorrhea Testing

There is increasing awareness associated with gonorrhea testing by organizations, leading to market growth. For instance, the Centers for Disease Control and Prevention recommended and issued guidelines for screening sexually transmitted diseases to create awareness towards screening programs for gonorrhea across the globe in 2022. It has issued separate gonorrhea screening guidelines for every population group, such as women, pregnant women, transgender and gender-diverse persons, and persons with HIV. Also, the United States National Institutes of Health announced on 5th August 2020 that a diagnostic test for detecting Neisseria gonorrhoeae by Visby Medical won the USD 19 million Antimicrobial Resistance Diagnostic Challenge. Thus, this factor boosts market growth.

Restraints/Challenges

• High Cost of Testing

Most of the tests available to detect gonorrheal infection typically need laboratory facilities, which tends to be a costly process. Numerous tools, such as microscopy, and cell culture, are highly sensitive; need technical control and management. These factors may negatively impact the gonorrhea testing industry's growth.

• Lack of Accuracy of Tests

It has been observed many times that testing devices can show false-negative results. The testing kits often lack accuracy because of improper sample loading and unloading. This lack of accuracy in Gonorrhea testing will restrain the market's growth.

This gonorrhea testing market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the gonorrhea testing market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Global Gonorrhea Testing Market Scope

The gonorrhea testing market is segmented on the basis of test type, sample type, and end user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Test Type

• Nucleic Acid Amplification
• Gram Stain
• Enzyme-linked immunosorbent assay
• Gonorrhea Culture
•  Rapid Test

Sample Type

• Blood
• Lymph Fluid
• Urine
• Throat Swab
• Penis/Vaginal Swab

End User

• Hospitals
• Pathology Lab
• Point of Care Testing

Gonorrhea Testing Market Regional Analysis/Insights

The gonorrhea testing market is analyzed and market size insights and trends are provided by test type, sample type and end user as referenced above.

The countries covered in the gonorrhea testing market report are U.S., Canada, and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the gonorrhea testing market because of the many care tests and high awareness among people associated with sexually transmitted diseases. Additionally, the wide availability of FDA-approved advanced sexually transmitted disease testing devices enhances the market growth.

Asia-Pacific is expected to witness significant growth due to increasing health awareness. The increasing prevalence of sexually transmitted infections in underdeveloped countries and the economic growth in these regions lead to market growth.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Healthcare Infrastructure growth Installed base and New Technology Penetration

The Gonorrhea testing market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for Gonorrhea testing market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the Gonorrhea testing market. The data is available for historic period 2011-2021.

Competitive Landscape and Gonorrhea Testing Market Share Analysis

The gonorrhea testing market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to gonorrhea testing market.

Some of the major players operating in the gonorrhea testing market are:

• Abbott (U.S.)
• Aposcience (Austria)
• BD (U.S.)
• Biocartis (Belgium)
• bioMérieux (France)
• Bio-Rad Laboratories Inc (U.S.)
• Cepheid (U.S.)
• Danaher (U.S.)
• DiaSorin S.p.A (Italy)
• GenMark Diagnostics Inc. (U.S.)
• Hologic Inc. (U.S.)
• OraSure Technologies Inc. (U.S.)
• Qualigen Technologies Inc. (U.S.)
• Quidel Corporation (U.S.)
• F. Hoffmann-La Roche Ltd (Switzerland)
• Thermo Fisher Scientific Inc (U.S.)
• MedMira Inc. (Canada)

SKU-56814